PAPER Mielke MM, Fowler NR, Whitson HE, Klepin HD, Trammell AR, Kulshreshtha A, O'Brien KS, Manchester M, Salive ME, Williamson J

Proceedings of the Alzheimer's Diagnosis in Older Adults with Chronic Conditions (ADACC) Network Inaugural Annual Conference.

J Gerontol A Biol Sci Med Sci. 2025 Mar 9; Epub 2025 Mar 9 PubMed.

PAPER Lee H, Shin S, Nam G, Kwak S, Cho YS, Hwang E, Oh S, Kim SY, Yoo SY, Lee JY

Longitudinal trajectories of cognitive, functional, and neuropsychiatric decline in Alzheimer's disease during COVID-19 lockdown in South Korea.

Sci Rep. 2025 Mar 8;15(1):8081. PubMed.

PAPER Liew TM

Distinct trajectories of subjective cognitive decline before diagnosis of neurocognitive disorders: Longitudinal modelling over 18 years.

J Prev Alzheimers Dis. 2025 Mar 7;:100123. Epub 2025 Mar 7 PubMed.

PAPER Lee S, Hahn C, Seong E, Choi HS

Corrigendum to "Reactive EEG biomarkers for diagnosis and prognosis of Alzheimer's disease and mild cognitive impairment" [Biosens. Bioelectron. 273 (2025) 117181].

Biosens Bioelectron. 2025 Mar 7;:117348. Epub 2025 Mar 7 PubMed. Corrected paper.

PAPER Rahman AU, Ali S, Saqia B, Halim Z, Al-Khasawneh MA, AlHammadi DA, Khan MZ, Ullah I, Alharbi M

Alzheimer's Disease Prediction Using 3D-CNNs: Intelligent Processing of Neuroimaging Data.

SLAS Technol. 2025 Mar 6;32:100265. Epub 2025 Mar 6 PubMed.

PAPER Xu C

Enhanced social interaction protects cognition by preserving synapse numbers.

Brain Res. 2025 Mar 6;1854:149552. Epub 2025 Mar 6 PubMed.

PAPER Mielke MM, Fielding RA, Atkinson EJ, Aversa Z, Schafer MJ, Cummings SR, Pahor M, Leeuwenburgh C, LeBrasseur NK

Biomarkers of cellular senescence predict risk of mild cognitive impairment: Results from the lifestyle interventions for elders (LIFE) study.

J Nutr Health Aging. 2025 Mar 7;29(5):100529. Epub 2025 Mar 7 PubMed.

PAPER Gong Y, Chen H, Gu Y, Shen J, Shen T, Ding Y, Lu M, Huang L, Yan M, Song P, Zhu Y, Rong S, Yuan C

Healthy dietary patterns in relation to cognitive performance and Alzheimer's disease mortality.

J Prev Alzheimers Dis. 2025 Mar 6;:100100. Epub 2025 Mar 6 PubMed.

PAPER Veljanoska E, Gomes S, Szende A, Cabra A, Munter-Young R, Gordois A

The Value of Positron Emission Tomography for Confirmation of Alzheimer's Disease in the Era of Amyloid-Targeting Therapies.

Value Health. 2025 Mar 5; Epub 2025 Mar 5 PubMed.

PAPER Zheng M

Snapshot of disease continuum centered on Alzheimer's disease: Exploring modifiable risk factors.

Prog Neuropsychopharmacol Biol Psychiatry. 2025 Mar 5;138:111316. Epub 2025 Mar 5 PubMed.

PAPER Chen H, Fang Z, Lin SL, Schachner M

L1CAM mimetic compound duloxetine improves cognitive impairment in 5xFAD mice and protects Aβ1-42-damaged HT22 cells.

Eur J Pharmacol. 2025 Mar 6;997:177476. Epub 2025 Mar 6 PubMed.

PAPER Elliott C, Jackson J, Findlay J, Williams G, Ghosh A, Ribe E, Ulmschneider M, Khan A, Ballard C, Aarsland D, Baillie GS, Harte M, Killick R

Blocking the Dkk1-LRP6 interaction prevents acute amyloid-β-driven cognitive impairment.

Cell Signal. 2025 Mar 6;131:111716. Epub 2025 Mar 6 PubMed.

PAPER Shahid F, Khan R, Mehmood A, Smadi AA, Ibrahim MM, Zheng Z

A Comprehensive Approach to Anticipating the Progression of Mild Cognitive Impairment.

Brain Res. 2025 Mar 6;:149549. Epub 2025 Mar 6 PubMed.

PAPER Kicik A, Kurt E, Hari E, Ulasoglu-Yildiz Ç, Gurvit H, Demiralp T

Impact of amygdala functional connectivity on cognitive impairment in Alzheimer's disease.

Neurol Sci. 2025 Mar 8; Epub 2025 Mar 8 PubMed.

PAPER Yu J, Zhou R, Liu S, Zheng J, Yan H, Su S, Chai N, Segal E, Jiang C, Guo K, Li CZ

Electrochemical Biosensors for the Detection of Exosomal microRNA Biomarkers for Early Diagnosis of Neurodegenerative Diseases.

Anal Chem. 2025 Mar 9; Epub 2025 Mar 9 PubMed.